Upcoming events

    • November 05, 2021
    • (UTC-03:00)
    • November 05, 2022
    • (UTC-03:00)
    Register

    The WISAM 2021 Virtual Conference was held on October 15-16, 2021. If you are interested in obtaining access to the session recordings, please register! You will receive a confirmation email with instructions to access once payment is received. Please contact our office with any questions! 

    Meet the Speakers | Learning Objectives

    Overview: Evolution or revolution? 2020 felt more like a revolution. Healthcare must respond to the ever-changing needs of our society and our patients; these changes seem to be occurring with increasing speed. This conference will focus on the changes occurring in addiction medicine to aid the busy practitioners of addiction care in staying abreast of current trends and provide new and better care.

    Target Audience: This educational activity is designed for professionals across disciplines who work in addiction treatment and prevention, including physicians, PAs, nurse practitioners, nurses, pharmacists, psychologists, social workers, mental health and substance abuse counselors, recovery coaches, law enforcement and public health workers.

    Session Recordings:

    • Integrating Addiction Psychiatry into a Consultation Framework: The University of Nebraska Medical Center Experience; VaKara M. Meyer Karre, MD
    • Benzodiazepines; Matt Felgus, MD, FASAM
    • Buprenorphine Treatment in the Age of Fentanyl; Elizabeth Salisbury-Afshar, MD MPH FAAFP FACPM DFASAM, Hannah Snyder, MD, Melissa Milne, DNP, APNP, FNP-BC, CARN-AP, Charles Schauberger, MD
    • Substance Use Disorders in Adolescents: Trends, Neurobiology and Treatments; Lalit Singh, MD, MPH
    • MAT During an Epidemic and Pandemic; Beth Collier, LCSW, CSAC, ICS
    • Gender Responsive Treatment for Women with Substance Use Disorders: A Family-Centered Approach; Claudia Vankoningsveld, MA, CADC, Melissa Lemke, MA
    • Treating Methamphetamine Use Disorders; Kristin DePrey, MA, LPC, CSAC, ICS
    • Understanding Proposed Changes to DHS 75 Rules; David Galbis-Reig, MD, DFASAM
    • ASAM Criteria for the Future State; Corey Waller, MD, MS, FACEP, DFASAM

    AMA Credit Designation Statement:

    The American Society of Addiction Medicine designates this enduring material for a maximum of 9.25AMA PRA Category 1 Credit (s). Physicians should claim only the credit commensurate with the extent of their participation in the activity.

    ACCME Accreditation Statement:

    This activity has been planned and implemented in accordance with the Essential Areas and policies of the Accreditation Council for Continuing Medical Education through the joint providership of The American Society of Addiction Medicine and The Wisconsin Society of Addiction Medicine (WISAM). The American Society of Addiction Medicine is accredited by the ACCME to provide continuing medical education for physicians.

    Planning Committee and Faculty Disclosure Information:
    (All faculty and planning committee members had no disclosures)

    WISAM 2021 Conference Planning Committee:

    • Subhadeep Barman, MD, FASAM
    • Ritu Bhatnagar, MD
    • Nameeta Dookeran, MD, MSc, FASAM
    • Matthew Felgus, MD, FASAM
    • David Galbis-Reig, MD, DFASAM
    • Ted Hall, PharmD
    • Mary-Anne Kowol, MD
    • Alison Miller, DO
    • Elizabeth Salisbury-Afshar, MD, MPH
    • Charles Schauberger, MD, MS

    WISAM 2021 Conference Faculty:

    • Elizabeth Collier, LCSW, CSAC, ICS
    • Kristin DePrey, MA, LPC, CSAC, ICS
    • Matt Felgus, MD, DFASAM
    • David Galbis-Reig, MD, DFASAM
    • VaKara M. Meyer Karre, MD
    • Claudia Van Koningsveld, MA, CADC
    • Melissa Lemke, MA
    • Melissa Milne, DNP, APNP, FNP-BC, CARN-AP
    • Elizabeth Salisbury-Afshar, MD, MPH, FAAFP, FACPM, DFASAM
    • Charles Schauberger, MD, MS
    • Lalit Singh, MD, MPH
    • Hannah Snyder, MD
    • Corey Waller, MD, MS, FACEP, DFASAM

    ASAM CME Committee Reviewer:
    Cara A. Poland, MD, MEd, DFASAM
    No disclosures

    In accordance with disclosure policies of ASAM and the ACCME, the effort is made to ensure balance, independence, objectivity, and scientific rigor in all CME activities. These policies include mitigating all possible relevant financial relationships for the Planning Committees and Presenters. All activity Planning Committee members and Presenters have disclosed relevant financial relationship information. The ASAM CME Committee has reviewed these disclosures and determined that the relationships are not inappropriate in the context of their respective presentations and are not inconsistent with the educational goals and integrity of the activity.

    • July 11, 2022
    • 3:00 PM - 5:00 PM
    • Virtual

    WISAM Quick Start to Treatment of Opioid Use Disorders: Buprenorphine Focus Course
    Monday, July 11, 2022 | 3:00-5:00 PM (central)

    Register today to participate in the Quick Start to Treatment of Opioid Use Disorders: Buprenorphine Focus Course, created by WISAM, in order to provide Primary Care Providers who are interested in treating opioid use disorders the opportunity to learn more and ask questions. With waiver requirements being reduced, primary care providers may be more interested in treating OUD, but still lack knowledge of mechanism of MAT and how to implement into their office based setting. 

    Register Here

    Learning Objectives:

    At the end of the course, the participant will be able to:

    • Explain the role of medications in the treatment of opioid use disorder (OUD)
    • Describe pharmacology of buprenorphine
    • Describe use of buprenorphine in OUD treatment from office-based setting
    • Understand how to manage common concerns in the treatment of OUD
    • Consider role of buprenorphine in their practice

    AMA Credit Designation Statement:

    The American Society of Addiction Medicine designates this live activity for a maximum of 2 AMA PRA Category 1 Credit (s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

    ACCME Accreditation Statement:

    This activity has been planned and implemented in accordance with the Essential Areas and policies of the Accreditation Council for Continuing Medical Education through the joint providership of The American Society of Addiction Medicine (ASAM) and the Wisconsin Society of Addiction Medicine. The American Society of Addiction Medicine is accredited by the ACCME to provide continuing medical education for physicians.

    Disclosure Information:

    • CME Committee Reviewer Disclosure Information: Herbert L. Malinoff, MD, FACP, DFASAM – No relevant financial disclosures
    • Faculty and Planner Disclosure Information: Ritu Bhatnagar, MD, MPH, FASAM – No Relevant Financial Disclosures; Dr. Subhadeep Barman, MD, FAPA, FASAM, FASCP – No Relevant Financial Disclosures
    • August 12, 2022
    • 8:00 AM - 12:30 PM
    • Zoom Webinar

    Buprenorphine X-Waiver Training Webinar

    DATE: Friday, August 12, 2022
    TIME:  8:00 AM - 12:30 PM
    LOCATION: Zoom Webinar (Link provided once registered)

    PRESENTER: David Galbis-Reig, MD, DFASAM

    Register Here

    After registering, you will receive a confirmation email containing information about joining the webinar.

    Training is provided complimentary to Wisconsin providers who are eligible to prescribe buprenorphine.  This session is presented as a live four-hour activity, which, when paired with ASAM's four-hour on-demand course, will provide necessary education for participates to apply for and obtain their  Buprenorphine Waver through the American Society of Addiction Medicine. 


    ASAM is an approved provider by CSAT/SAMHSA of DATA 2000 training. This blended format combines 4 hours of self-paced online learning with 4 hours of live learning for a total of 8 hours.  The online portion is completed before the live portion and will introduce learners to treating opioid use disorder with medications. Prior to the live course, learners will be issued access to the online portion of the blended course through the ASAM e-Learning Center. The live portion of the course focuses on special populations and cases.

    ACCREDITATION: The American Society of Addiction Medicine (ASAM) is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

    DESIGNATION: The American Society of Addiction Medicine designates this live activity for a maximum of AMA PRA Category 1 Credits. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

    The American Society of Addiction Medicine designates this enduring material for a maximum of AMA PRA Category 1 Credits. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

    ASAM does not award partial credit for this 8-hour course. All 8 hours must be completed to receive CME credit.

    • August 15, 2022
    • 2:00 PM - 4:00 PM
    • Virtual

    WISAM Quick Start to Treatment of Opioid Use Disorders: Buprenorphine Focus Course
    Monday, August 15, 2022 | 2:00-4:00 PM (central)

    Register today to participate in the Quick Start to Treatment of Opioid Use Disorders: Buprenorphine Focus Course, created by WISAM, in order to provide Primary Care Providers who are interested in treating opioid use disorders the opportunity to learn more and ask questions. With waiver requirements being reduced, primary care providers may be more interested in treating OUD, but still lack knowledge of mechanism of MAT and how to implement into their office based setting. 

    Register Here

    Learning Objectives:

    At the end of the course, the participant will be able to:

    • Explain the role of medications in the treatment of opioid use disorder (OUD)
    • Describe pharmacology of buprenorphine
    • Describe use of buprenorphine in OUD treatment from office-based setting
    • Understand how to manage common concerns in the treatment of OUD
    • Consider role of buprenorphine in their practice

    AMA Credit Designation Statement:

    The American Society of Addiction Medicine designates this live activity for a maximum of 2 AMA PRA Category 1 Credit (s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

    ACCME Accreditation Statement:

    This activity has been planned and implemented in accordance with the Essential Areas and policies of the Accreditation Council for Continuing Medical Education through the joint providership of The American Society of Addiction Medicine (ASAM) and the Wisconsin Society of Addiction Medicine. The American Society of Addiction Medicine is accredited by the ACCME to provide continuing medical education for physicians.

    Disclosure Information:

    • CME Committee Reviewer Disclosure Information: Herbert L. Malinoff, MD, FACP, DFASAM – No relevant financial disclosures
    • Faculty and Planner Disclosure Information: Ritu Bhatnagar, MD, MPH, FASAM – No Relevant Financial Disclosures; Dr. Subhadeep Barman, MD, FAPA, FASAM, FASCP – No Relevant Financial Disclosures
    • October 13, 2022
    • October 14, 2022
    • Madison, WI


    SAVE THE DATE

    Mark your calendars and plan to join us for WISAM's 2022 Annual Conference. The event will be held in-person at the Pyle Center in Madison, WI on Thursday, October 13 and Friday, October 14, 2022.

    • October 13, 2022
    • October 14, 2022
    • Madison, WI
    Register

    WISAM 2022 Annual Conference - Vendor Registration

    WISAM will be back in-person for the 2022 Annual Conference on October 13-14, 2022! This event is not possible without the support of our industry friends. We thank all of our past supporters, and welcome new partners. This year's hybrid format creates some unique and exciting ways for you to support and participate in the event. For more information, please view our prospectus below.
    • App Sponsor $2,500 (one available)
    • Breakfast Sponsor $2,000 ( (one available)
    • Lunch Sponsor $2,000 (one available)
    • Exhibit Only - $1,000 (unlimited)
    • Non-Profit Booth - $250 (one left)

    All levels include:

    • 6’ skirted table and two chairs
    • Mention of your organization’s participation in conference materials
    • Dedicated display time in exhibit hall
    • Roster of attendees distributed at the time of the conference
    • Complimentary continental breakfast, lunch and refreshments in the exhibit hall

    *** Booth electricity available for $50.00 | Additional representatives $75.00/ each

    VIEW PROSPECTUS HERE

    DISCLAIMER: This program is designed for WISAM members, invited guests and vendors whose products and services align with the WISAM mission. All applications for exhibit space will be considered. WISAM reserves the right to reject any application that WISAM in its sole discretion determines inconsistent with the mission of the organization.

    • October 14, 2022
    • 12:30 PM - 12:45 PM
    • Madison, WI

    WISAM 2022 Annual Business Meeting

    WISAM's 2022 Annual Meeting is scheduled for Friday, October 14 from 12:30-12:45 PM during the lunch break at the WISAM Annual Conference. All members are encouraged to attend. Agenda TBA.

Past events

June 28, 2022 WISAM Public Policy Committee Meeting
June 23, 2022 WISAM Open Exchange
June 23, 2022 WISAM Beyond the Waiver Course
June 20, 2022 WISAM Quick Start to Treatment Course
June 17, 2022 Buprenorphine X-Waiver Training Webinar
June 14, 2022 WHN Panel Series Event: Tackling the Opioid Crisis
May 26, 2022 WISAM Open Exchange
May 10, 2022 DHS Opioids, Stimulants, and Trauma Summit
April 28, 2022 WISAM Open Exchange: Careers in Addiction
April 25, 2022 Buprenorphine X-Waiver Training Webinar
March 31, 2022 ASAM 53rd Annual Conference - Innovations in Addiction Medicine and Science
March 25, 2022 Buprenorphine X-Waiver Training Webinar
March 24, 2022 WISAM Open Exchange
March 07, 2022 2022 Addiction Medicine Advocacy Conference
March 02, 2022 WISAM Public Policy Committee Meeting
February 28, 2022 Buprenorphine X-Waiver Training Webinar
February 24, 2022 WISAM Open Exchange
February 22, 2022 Social Determinants of Addiction 101
February 08, 2022 Wisconsin Doctor Day
January 27, 2022 WISAM Open Exchange
January 20, 2022 National Drug and Alcohol Facts Week® (NDAFW)
December 09, 2021 AAAP 2021 Annual Meeting and Scientific Symposium
December 08, 2021 WISAM Public Policy Committee Meeting
December 07, 2021 WHN Newsmaker Series Event - Hospital CEO Roundtable
October 27, 2021 17th Annual Mental Health & Substance Use Recovery Conference
October 18, 2021 National Addiction Treatment Week
October 15, 2021 WISAM Annual Business Meeting
October 15, 2021 WISAM 2021 Virtual Conference
October 15, 2021 WISAM 2021 Virtual Sponsors + Exhibitors
October 10, 2021 WISAM Virtual Conference Series: On-Demand
September 15, 2021 Trauma-Informed Care Webinar Series
August 26, 2021 WISAM Open Exchange
July 22, 2021 WISAM Open Exchange
July 22, 2021 Summer Lunch and Learn: New Buprenorphine Practice Guidelines
July 14, 2021 Buprenorphine X-Waiver Training Webinar
July 13, 2021 Panel Series: Addressing health inequities beyond COVID-19
June 30, 2021 Alternatives to Opioids in Treating Acute and Chronic Pain
June 25, 2021 Buprenorphine X-Waiver Training Webinar
June 24, 2021 WISAM Open Exchange
June 11, 2021 Buprenorphine X-Waiver Training Webinar
May 27, 2021 WISAM Open Exchange
May 19, 2021 Moving Past the Pandemic and Returning to In-person Care: Seizing Opportunities to Address Tobacco Addiction
May 17, 2021 Buprenorphine X-Waiver Training Webinar
May 14, 2021 Buprenorphine Boot Camp
May 07, 2021 Buprenorphine X-Waiver Training Webinar
May 05, 2021 Wisconsin Doctor Day 2021
April 30, 2021 Buprenorphine X-Waiver Training Webinar
April 22, 2021 WISAM Open Exchange
April 22, 2021 ASAM Virtual 2021
April 05, 2021 Buprenorphine X-Waiver Training Webinar
April 01, 2021 WISAM Meet Up @ ASAM Virtual
March 25, 2021 WISAM Open Exchange
March 22, 2021 National Drug and Alcohol Facts Week
March 22, 2021 Addiction Medicine Advocacy Conference
March 19, 2021 Buprenorphine X-Waiver Training Webinar
March 17, 2021 Engaging Patients & Maximizing Visits through Telemedicine
March 15, 2021 The Periscope Project Info Sessions
March 05, 2021 Buprenorphine X-Waiver Training Webinar
March 04, 2021 WPA 2021 Annual Conference: Clinical Challenges and Novel Approaches
March 03, 2021 A New Era: Diagnosing and Treating Hepatitis C (HCV) in Primary Care Settings
February 26, 2021 Monthly Periscope Educational Webinar Series
February 25, 2021 WISAM Open Exchange
February 05, 2021 2021 ACMT Total Tox Course (Virtual)
January 28, 2021 WISAM Open Exchange
January 14, 2021 Addressing Emergent and Urgent Physical Health Issues in Women Participating in Substance Use Disorder Treatment
December 18, 2020 Introduction to AMNet: Addiction Medicine Practice-based Research Network
December 02, 2020 Introduction to the Bucket Approach Training
November 17, 2020 Buprenorphine X-Waiver Training Webinar
November 13, 2020 WISAM Annual Membership Meeting
November 11, 2020 WHN Webinar - COVID-19: What's next for Wisconsin?
October 23, 2020 Buprenorphine X-Waiver Training Webinar
October 19, 2020 National Addiction Treatment Week
October 16, 2020 Buprenorphine Boot Camp
September 14, 2020 Buprenorphine X-Waiver Training Webinar
September 11, 2020 WISAM Virtual Conference Series
September 10, 2020 Heroes for Healthcare Event
September 02, 2020 Racism, Diversity and Social Justice – WMS Virtual Town Hall
August 26, 2020 ACMT 2020 Total Tox Course
August 20, 2020 Breastfeeding and Substance Use: Current Research and Realities
August 18, 2020 Buprenorphine X-Waiver Training Webinar
August 18, 2020 WISAM Virtual Exhibit Hall
August 13, 2020 Exact Sciences CEO Kevin Conroy
July 30, 2020 Wisconsin Medicaid Telehealth Expansion Webinar: Stakeholder Input Session for Providers
July 21, 2020 Buprenorphine X-Waiver Training Webinar
July 16, 2020 ASAM Board Exam Study Course - Virtual
July 14, 2020 WHN: Coexisting with COVID-19
June 15, 2020 Buprenorphine X-Waiver Training Webinar
May 29, 2020 Buprenorphine X-Waiver Training Webinar
May 22, 2020 Buprenorphine X-Waiver Training Webinar
May 15, 2020 Buprenorphine X-Waiver Training Webinar
May 05, 2020 DHS 2020 Opioid Forum (Postponed)
April 30, 2020 OUD & the Emergency Department Experience During the COVID-19 Pandemic
April 24, 2020 Buprenorphine X-Waiver Course (Cancelled)
April 24, 2020 Buprenorphine X-Waiver Course (Cancelled)
April 17, 2020 WMS Annual Fundraising Silent Auction: ONLINE!
April 15, 2020 Newsmaker webinar with Froedtert Health CEO Cathy Jacobson
April 14, 2020 WI DHS COVID-19 Videoconference for Behavioral Health Providers
April 09, 2020 WI DHS COVID-19 Videoconference for Behavioral Health Providers
April 07, 2020 COVID-19 update with Marshfield Clinic Health System CEO Dr. Sue Turney
April 07, 2020 Webinar - How the Stimulus Can Help You
April 02, 2020 ASAM 2020 Annual Conference (ONLINE)
March 26, 2020 Town Hall Teleconference Call
March 17, 2020 Buprenorphine X-Waiver Course (Cancelled)
February 27, 2020 Town Hall Teleconference Call
February 18, 2020 Buprenorphine X-Waiver Course
February 10, 2020 Newsmaker Event - Deputy Insurance Commissioner Nathan Houdek
January 29, 2020 Doctor Day 2020
January 23, 2020 Town Hall Teleconference Call
November 06, 2019 Buprenorphine X-Waiver Course
October 28, 2019 Buprenorphine X-Waiver Course
October 21, 2019 National Addiction Treatment Week
October 15, 2019 2nd Annual WI Opioid & Meth Summit
September 26, 2019 WISAM 2019 Annual Conference
September 26, 2019 WISAM 2019 Annual Conference Vendors
August 27, 2019 Buprenorphine X-Waiver Course
August 16, 2019 Buprenorphine X-Waiver Course
July 29, 2019 Buprenorphine X-Waiver Course
July 25, 2019 ASAM Review Course in Addiction Medicine
July 16, 2019 Buprenorphine X-Waiver Course
June 28, 2019 Buprenorphine X-Waiver Course
June 04, 2019 Buprenorphine X-Waiver Course
May 23, 2019 WISAM Telephone Town Hall
May 22, 2019 Complex Pain Case Conference
May 17, 2019 Buprenorphine X-Waiver Course
May 16, 2019 Overcoming Addiction Together
April 16, 2019 Buprenorphine X-Waiver Course
April 06, 2019 WISAM Meeting at ASAM 50th Annual Conference
April 05, 2019 From Asthma to Zika: A Physician's Guide to Summer
March 28, 2019 WISAM Telephone Town Hall
March 18, 2019 Buprenorphine X-Waiver Course
February 28, 2019 WISAM Telephone Town Hall
February 20, 2019 Buprenorphine X-Waiver Course
January 24, 2019 WISAM Telephone Town Hall
September 29, 2018 WISAM 2018 CLINICAL WORKSHOPS
September 27, 2018 WISAM 2018 Annual Conference
September 27, 2018 WISAM 2018 Annual Conference Vendors
July 10, 2018 WHN Panel Series Event
June 20, 2018 WISAM 2018 Webinar Series
May 08, 2018 Treating an Epidemic: Solutions and Challenges in Overcoming the Opioid Crisis
April 13, 2018 Wisconsin Medical Society Foundation: Annual Fundraising Dinner and Silent Auction
April 12, 2018 ASAM 49th Annual Conference
January 30, 2018 2018 Doctor Day
September 14, 2017 2017 Wisconsin Society of Addiction Medicine Annual Conference
September 14, 2017 WISAM 2017 Annual Conference Vendor
August 30, 2017 The Opioid Crisis: Innovative Health Communication Strategies
July 19, 2017 WI Health News Conference: Health Reform: What does it mean for Wisconsin?
June 05, 2017 WI Health News: JFC Co-Chair Nygren to headline June 5 Newsmaker Event
April 24, 2017 Addiction Treatment Gap Awareness

Wisconsin Society of Addiction Medicine

563 Carter Court, Suite B
Kimberly, WI 54136
P: 920-750-7727
E: WISAM@badgerbay.co


Follow Us

Copyright © 2018 WISAM All rights reserved.  | Terms of Use | Privacy Policy

The Wisconsin Society of Addiction Medicine (WISAM) is headquartered in Kimberly, WI.
Contact us today for more information about our organization!

Powered by Wild Apricot Membership Software